TERNS PHARMACEUTICALS INC (TERN)
US8808811074 - Common Stock
Terns Pharmaceuticals is Now Oversold (TERN)
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
FOSTER CITY, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.
Commit To Purchase Terns Pharmaceuticals At $5, Earn 37.2% Annualized Using Options
Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich
Some of the market’s favorite biotech stocks have created immense wealth, as evidenced with the recent weight-loss drug stock boom.
Terns Pharmaceuticals (TERN) Shares Cross Below 200 DMA
Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy?
Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.
TERN Stock Earnings: Terns Pharma Meets EPS for Q4 2023
TERN stock results show that Terns Pharma met analyst estimates for earnings per share the fourth quarter of 2023.
TERN Stock Earnings: Terns Pharma Meets EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Terns Pharma (NASDAQ:TERN) just reported results for the fourth quarter of 2023...
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
Interim data from initial dose escalation cohorts from Phase 1 trial of TERN-701 (allosteric BCR-ABL) for treatment of CML expected in second half of 2024 ...
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
FOSTER CITY, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
FOSTER CITY, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Friday Sector Leaders: Semiconductors, Drugs
Terns Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish for TERN
Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
Proven Industry Executive Brings More Than 25 Years of Leadership Experience
Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
Proven Industry Executive Brings More Than 25 Years of Leadership Experience...
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
Plans to advance diverse pipeline of programs in oncology and metabolic diseases Anticipates key proof-of-concept readouts for TERN-701 (CML) and TERN-601...
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Commit To Buy Terns Pharmaceuticals At $5, Earn 36.7% Annualized Using Options
Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
FOSTER CITY, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...
Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer
Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer
FOSTER CITY, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage...